{
    "id": 26676,
    "fullName": "ATG7 - BRAF",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ATG7-BRAF results from the fusion of ATG7 and BRAF, which leads to increased phosphorylation of Erk and is transforming in cultured cells (PMID: 28512244). ATG7-BRAF has been identified in cutaneous melanoma (PMID: 26091043).",
            "references": [
                {
                    "id": 9257,
                    "pubMedId": 28512244,
                    "title": "Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28512244"
                },
                {
                    "id": 16176,
                    "pubMedId": 26091043,
                    "title": "Genomic Classification of Cutaneous Melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26091043"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 10533,
        "geneSymbol": "ATG7",
        "terms": [
            "ATG7",
            "APG7-LIKE",
            "APG7L",
            "GSA7"
        ]
    },
    "variant": "ATG7 - BRAF",
    "createDate": "07/03/2017",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 11369,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing ATG7-BRAF demonstrated sensitivity to Mekinist (trametinib) in culture (PMID: 28512244).",
            "molecularProfile": {
                "id": 27971,
                "profileName": "ATG7 - BRAF"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9257,
                    "pubMedId": 28512244,
                    "title": "Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28512244"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11368,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing ATG7-BRAF demonstrated sensitivity to Tafinlar (dabrafenib) in culture (PMID: 28512244).",
            "molecularProfile": {
                "id": 27971,
                "profileName": "ATG7 - BRAF"
            },
            "therapy": {
                "id": 3,
                "therapyName": "Dabrafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9257,
                    "pubMedId": 28512244,
                    "title": "Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28512244"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27971,
            "profileName": "ATG7 - BRAF",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}